phorbol 12,13-dibutyrate has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azmitia, EC; Kramer, HK; Poblete, JC | 1 |
| Hashimoto, T; Kitamura, N; Nishino, N; Saito, N; Tanaka, C; Yoshihara, C | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and Nerve Degeneration
| Article | Year |
|---|---|
3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals.
Topics: Animals; Binding Sites; Biological Transport; Cerebral Cortex; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Paroxetine; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Second messenger systems in brains of patients with Parkinson's or Huntington's disease.
Topics: Aged; Animals; Brain; Brain Mapping; Calcium; Cell Death; Corpus Striatum; Female; Humans; Huntington Disease; Inositol 1,4,5-Trisphosphate; Male; Middle Aged; Nerve Degeneration; Neurotransmitter Agents; Parkinson Disease; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Second Messenger Systems; Substantia Nigra | 1993 |